Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice

Cannabinoids are known to modulate oligodendrogenesis and developmental CNS myelination. However, the cell-autonomous action of these compounds on oligodendroglial cells in vivo, and the molecular mechanisms underlying these effects have not yet been studied. Here, by using oligodendroglial precurso...

ver descrição completa

Detalhes bibliográficos
Autores: Sánchez De La Torre, Aníbal, Aguado Sánchez, Tania, Huerga-Gómez, Alba, Santamaría, Silvia, Gentile, Antonietta, Chara, Juan Carlos, Matute, Carlos, Monory, Krisztina, Mato, Susana, Guzmán Pastor, Manuel, Lutz, Beat, Galve Roperh, Ismael, Palazuelos Diego, Javier
Tipo de documento: artigo
Data de publicação:2022
País:España
Recursos:Universidad Complutense de Madrid (UCM)
Repositório:Docta Complutense
Idioma:inglês
OAI Identifier:oai:docta.ucm.es:20.500.14352/88941
Acesso em linha:https://hdl.handle.net/20.500.14352/88941
Access Level:Acceso aberto
Palavra-chave:615.9
591.18
612.8
Cannabinoid CB1 receptor
Oligodendrogenesis
Myelination
Bioquímica (Biología)
Biología molecular (Biología)
Neurociencias (Biológicas)
2403 Bioquímica
2407 Biología Celular
2490 Neurociencias
id ES_b40a40173c71ff5a8e2b5eed1e7ba04d
oai_identifier_str oai:docta.ucm.es:20.500.14352/88941
network_acronym_str ES
network_name_str España
repository_id_str
spelling Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in miceSánchez De La Torre, AníbalAguado Sánchez, TaniaHuerga-Gómez, AlbaSantamaría, SilviaGentile, AntoniettaChara, Juan CarlosMatute, CarlosMonory, KrisztinaMato, SusanaGuzmán Pastor, ManuelLutz, BeatGalve Roperh, IsmaelPalazuelos Diego, Javier615.9591.18612.8Cannabinoid CB1 receptorOligodendrogenesisMyelinationBioquímica (Biología)Biología molecular (Biología)Neurociencias (Biológicas)2403 Bioquímica2407 Biología Celular2490 NeurocienciasCannabinoids are known to modulate oligodendrogenesis and developmental CNS myelination. However, the cell-autonomous action of these compounds on oligodendroglial cells in vivo, and the molecular mechanisms underlying these effects have not yet been studied. Here, by using oligodendroglial precursor cell (OPC)-targeted genetic mouse models, we show that cannabinoid CB1 receptors exert an essential role in modulating OPC differentiation at the critical periods of postnatal myelination. We found that selective genetic inactivation of CB1 receptors in OPCs in vivo perturbs oligodendrogenesis and postnatal myelination by altering the RhoA/ROCK signaling pathway, leading to hypomyelination, and motor and cognitive alterations in young adult mice. Conversely, pharmacological CB1 receptor activation, by inducing E3 ubiquitin ligase-dependent RhoA proteasomal degradation, promotes oligodendrocyte development and CNS myelination in OPCs, an effect that was not evident in OPC-specific CB1 receptordeficient mice. Moreover, pharmacological inactivation of ROCK in vivo overcomes the defects in oligodendrogenesis and CNS myelination, and behavioral alterations found in OPC-specific CB1 receptor-deficient mice. Overall, this study supports a cellautonomous role for CB1 receptors in modulating oligodendrogenesis in vivo, which may have a profound impact on the scientific knowledge and therapeutic manipulation of CNS myelination by cannabinoids.Springer NatureUniversidad Complutense de Madrid20222022-01-0120222022-01-01journal articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/20.500.14352/88941reponame:Docta Complutenseinstname:Universidad Complutense de Madrid (UCM)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Attribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:docta.ucm.es:20.500.14352/889412026-06-02T12:44:21Z
dc.title.none.fl_str_mv Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice
title Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice
spellingShingle Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice
Sánchez De La Torre, Aníbal
615.9
591.18
612.8
Cannabinoid CB1 receptor
Oligodendrogenesis
Myelination
Bioquímica (Biología)
Biología molecular (Biología)
Neurociencias (Biológicas)
2403 Bioquímica
2407 Biología Celular
2490 Neurociencias
title_short Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice
title_full Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice
title_fullStr Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice
title_full_unstemmed Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice
title_sort Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice
dc.creator.none.fl_str_mv Sánchez De La Torre, Aníbal
Aguado Sánchez, Tania
Huerga-Gómez, Alba
Santamaría, Silvia
Gentile, Antonietta
Chara, Juan Carlos
Matute, Carlos
Monory, Krisztina
Mato, Susana
Guzmán Pastor, Manuel
Lutz, Beat
Galve Roperh, Ismael
Palazuelos Diego, Javier
author Sánchez De La Torre, Aníbal
author_facet Sánchez De La Torre, Aníbal
Aguado Sánchez, Tania
Huerga-Gómez, Alba
Santamaría, Silvia
Gentile, Antonietta
Chara, Juan Carlos
Matute, Carlos
Monory, Krisztina
Mato, Susana
Guzmán Pastor, Manuel
Lutz, Beat
Galve Roperh, Ismael
Palazuelos Diego, Javier
author_role author
author2 Aguado Sánchez, Tania
Huerga-Gómez, Alba
Santamaría, Silvia
Gentile, Antonietta
Chara, Juan Carlos
Matute, Carlos
Monory, Krisztina
Mato, Susana
Guzmán Pastor, Manuel
Lutz, Beat
Galve Roperh, Ismael
Palazuelos Diego, Javier
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidad Complutense de Madrid
dc.subject.none.fl_str_mv 615.9
591.18
612.8
Cannabinoid CB1 receptor
Oligodendrogenesis
Myelination
Bioquímica (Biología)
Biología molecular (Biología)
Neurociencias (Biológicas)
2403 Bioquímica
2407 Biología Celular
2490 Neurociencias
topic 615.9
591.18
612.8
Cannabinoid CB1 receptor
Oligodendrogenesis
Myelination
Bioquímica (Biología)
Biología molecular (Biología)
Neurociencias (Biológicas)
2403 Bioquímica
2407 Biología Celular
2490 Neurociencias
description Cannabinoids are known to modulate oligodendrogenesis and developmental CNS myelination. However, the cell-autonomous action of these compounds on oligodendroglial cells in vivo, and the molecular mechanisms underlying these effects have not yet been studied. Here, by using oligodendroglial precursor cell (OPC)-targeted genetic mouse models, we show that cannabinoid CB1 receptors exert an essential role in modulating OPC differentiation at the critical periods of postnatal myelination. We found that selective genetic inactivation of CB1 receptors in OPCs in vivo perturbs oligodendrogenesis and postnatal myelination by altering the RhoA/ROCK signaling pathway, leading to hypomyelination, and motor and cognitive alterations in young adult mice. Conversely, pharmacological CB1 receptor activation, by inducing E3 ubiquitin ligase-dependent RhoA proteasomal degradation, promotes oligodendrocyte development and CNS myelination in OPCs, an effect that was not evident in OPC-specific CB1 receptordeficient mice. Moreover, pharmacological inactivation of ROCK in vivo overcomes the defects in oligodendrogenesis and CNS myelination, and behavioral alterations found in OPC-specific CB1 receptor-deficient mice. Overall, this study supports a cellautonomous role for CB1 receptors in modulating oligodendrogenesis in vivo, which may have a profound impact on the scientific knowledge and therapeutic manipulation of CNS myelination by cannabinoids.
publishDate 2022
dc.date.none.fl_str_mv 2022
2022-01-01
2022
2022-01-01
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/20.500.14352/88941
url https://hdl.handle.net/20.500.14352/88941
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Springer Nature
publisher.none.fl_str_mv Springer Nature
dc.source.none.fl_str_mv reponame:Docta Complutense
instname:Universidad Complutense de Madrid (UCM)
instname_str Universidad Complutense de Madrid (UCM)
reponame_str Docta Complutense
collection Docta Complutense
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869417227598430208
score 15,301629